Next, while similar levels of IL-6 were observed in non-stimulated CF cells, at 1 month after ETI LPS-treated cells showed reduced levels of IL-6, although differences did not reach statistical significance ( figure 7 ).
← all excerpts
Elexacaftor/tezacaftor/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis.
1
—
—